ClinConnect ClinConnect Logo
Search / Trial NCT06986759

Comparative Effects of Laser and Extracorpeal Shock Wave in Patients With Achilles Tendinopathy.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 15, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Pain Function Range Of Motion

ClinConnect Summary

This clinical trial is looking at two different treatments for Achilles tendinopathy, a painful condition that affects the tendon at the back of your ankle. The study aims to compare the effects of laser therapy and extracorporeal shock wave therapy on patients who have been diagnosed with chronic Achilles tendinopathy. This condition can make it hard to walk, run, or participate in other physical activities, and effective treatment is important for recovery.

To join the study, participants need to be between 18 and 40 years old and have a confirmed diagnosis of chronic Achilles tendinopathy, with a pain score of more than 2 on a scale of 0 to 10. However, individuals with certain medical conditions or those who have had specific treatments for their tendon pain may not be eligible. If you qualify and decide to participate, you can expect to receive one of the two treatments and help contribute to finding the best way to manage this common condition. The trial is not yet recruiting participants, but it's an important step toward improving treatment options for Achilles tendinopathy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age of patients 18-40.
  • Diagnosed with chronic Achillis tendinopathy and NPRS rating more than 2.
  • Both male and female.
  • Patient must be diagnosed with Achillis Tendinopathy by single leg raise or Thompson test.
  • Exclusion Criteria:
  • contraindications to LLLT to the area of the Achilles tendon.
  • comorbid musculoskeletal or serious conditions that may have confounded treatment or anticipated recovery .
  • nonsteroidal anti-inflammatory drug use steroid injections or surgery for the condition; insertional tendinopathy or bursitis (retrocalcaneal or Achilles; determined by clinical examination.
  • neurologic signs; and adverse neural tension affecting the sciatic or sural nerve.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Muzna Munir, PhD*

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported